Rare diseases
Investigational molecules
Locations
Study of Benralizumab Safety, Pharmacokinetics, and Efficacy in Children with Eosinophilic Disease
FrancePhase III Randomized Study of Intravesical Alpha1H as Neoadjuvant Therapy in Patients with Low- to Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer
CzechiaA Phase 3 Study of Enpatoran to Treat Active Cutaneous Lupus in Patients With or Without Systemic Disease
BelgiumPhase 2 Study of PF-08634404 with Carboplatin and Etoposide in Adults with Untreated Small Cell Lung Cancer
FranceStudy of RMC-6291 with ivonescimab drug combination in patients with advanced RAS‑mutated solid tumors
BelgiumPhase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)
BelgiumStudy of telisotuzumab adizutecan plus drug combination in adults with refractory metastatic colorectal cancer
BelgiumSafety of flecainide acetate compared with amiodarone hydrochloride and sotalol in patients with atrial fibrillation and stable coronary artery disease
BelgiumRandomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients
AustriaEverolimus-Based Calcineurin-Inhibitor-Free Immunosuppression with Drug Combination in Patients One Year After Liver Transplantation
GermanyStudy of REGN7508 versus apixaban for treating and preventing cancer-associated blood clots in adults with solid or blood cancers
BulgariaSafety and Feasibility of Home Use On-Body Injection System for Subcutaneous Ocrelizumab in Adults with Multiple Sclerosis
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
